UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Comparative analyses of seven algorithms for copy number variant identification from single nucleotide polymorphism arrays

Nucleic acids research, 2010-05, Vol.38 (9), p.e105

2010

Volltextzugriff (PDF)

Gene expression profile in human trabecular meshwork from patients with primary open-angle glaucoma

Investigative ophthalmology & visual science, 2013-09, Vol.54 (9), p.6382-6389

2013

Volltextzugriff (PDF)

Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing

Clinical cancer research, 2015-08, Vol.21 (15), p.3442-3452

2015

Volltextzugriff (PDF)

Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors

Cancer chemotherapy and pharmacology, 2012-08, Vol.70 (2), p.251-258

2012

Volltextzugriff (PDF)

Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data

Cancer informatics, 2014-01, Vol.2014 (Suppl. 4), p.1-9

2014

Volltextzugriff (PDF)

TOP-345 Clinical and HLA associations of fluoroquinolone induced liver injury: results from the drug induced liver injury network (DILIN)

Journal of hepatology, 2024-06, Vol.80, p.S114-S115

2024

Volltextzugriff (PDF)

A phase I study of ABT‐510 plus bevacizumab in advanced solid tumors

Cancer medicine (Malden, MA), 2013-06, Vol.2 (3), p.316-324

2013

Volltextzugriff (PDF)

Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2013-11, Vol.145 (5), p.1076-1087

2013

Volltextzugriff (PDF)

Integrative pathway analysis using graph-based learning with applications to TCGA colon and ovarian data

Cancer informatics, 2014-07, Vol.2014 (Suppl. 4), p.1-9

2014

Volltextzugriff (PDF)

HLA-B53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans

The American journal of gastroenterology, 2024-01, Vol.119 (1), p.200-202

2024

Volltextzugriff (PDF)

Human Leukocyte Antigen B14:01 and B35:01 Are Associated With Trimethoprim‐Sulfamethoxazole Induced Liver Injury

Hepatology (Baltimore, Md.), 2021-01, Vol.73 (1), p.268-281

2021

Volltextzugriff (PDF)

Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease

Hepatology (Baltimore, Md.), 2014-02, Vol.59 (2), p.471-482

2014

Volltextzugriff (PDF)

Drug-Induced Liver Injury in Pregnancy: The U.S. Drug-Induced Liver Injury Network Experience

Obstetrics and gynecology (New York. 1953), 2024-06, Vol.143 (6), p.819

2024

Volltextzugriff (PDF)

When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network

The American journal of gastroenterology, 2023-12, Vol.118 (12), p.2301-2304

2023

Volltextzugriff (PDF)

Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury

Journal of hepatology, 2023-02, Vol.78 (2), p.293-300

2023

Volltextzugriff (PDF)

Capturing Reality for a Billiards Simulation

Augmented Reality, Virtual Reality, and Computer Graphics, p.289-298

Volltextzugriff (PDF)

Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate

Gastroenterology (New York, N.Y. 1943), 2023-03, Vol.164 (3), p.454-466

2023

Volltextzugriff (PDF)

Drug‐induced liver injury (DILI) ascribed to non‐steroidal anti‐inflammatory drugs (NSAIDs) in the USA—Update with genetic correlations

Liver international, 2024-06, Vol.44 (6), p.1409-1421

2024

Volltextzugriff (PDF)

HLA-B14:01 and HLA-B35:01 are associated with trimethoprim-sulfamethoxazole induced liver injury

Hepatology (Baltimore, Md.), 2021-01, Vol.73 (1), p.268-281

2021

Volltextzugriff (PDF)

FRI-079-HLA B14:01 is associated with Trimethoprim-sulfamethoxazole induced liver injury

Journal of hepatology, 2019-04, Vol.70 (1), p.e419-e419

2019

Volltextzugriff (PDF)

Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors

Cancer chemotherapy and pharmacology, 2012-08, Vol.70 (2), p.251-258

2012

Volltextzugriff (PDF)

Modulation of pharmacodynamic (PD) biomarkers in dermal biopsies from patients treated on a phase I study of bevacizumab (Bev) in combination with everolimus (Ev) and erlotinib (Erl) for advanced solid tumors

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e13589-e13589

2012

Volltextzugriff (PDF)

A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2015-02, Vol.75 (2), p.343-352

2015

Volltextzugriff (PDF)

Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data: Supplement Issue: Array Platform Modeling and Analysis (A)

Cancer informatics, 2014-01, Vol.13s4, p.CIN.S13634

2014

Volltextzugriff (PDF)

An Experiment for Background Subtraction in a Dynamic Scene

Advances in Artificial Intelligence, p.420-425

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Comparative analyses of seven algorithms for copy number variant identification from single nucleotide polymorphism arrays

Gene expression profile in human trabecular meshwork from patients with primary open-angle glaucoma

Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing

Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors

Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data

TOP-345 Clinical and HLA associations of fluoroquinolone induced liver injury: results from the drug induced liver injury network (DILIN)

A phase I study of ABT‐510 plus bevacizumab in advanced solid tumors

Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease

Integrative pathway analysis using graph-based learning with applications to TCGA colon and ovarian data

HLA-B53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans

Human Leukocyte Antigen B14:01 and B35:01 Are Associated With Trimethoprim‐Sulfamethoxazole Induced Liver Injury

Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease

Drug-Induced Liver Injury in Pregnancy: The U.S. Drug-Induced Liver Injury Network Experience

When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network

Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury

Capturing Reality for a Billiards Simulation

Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate

Drug‐induced liver injury (DILI) ascribed to non‐steroidal anti‐inflammatory drugs (NSAIDs) in the USA—Update with genetic correlations

HLA-B14:01 and HLA-B35:01 are associated with trimethoprim-sulfamethoxazole induced liver injury

FRI-079-HLA B14:01 is associated with Trimethoprim-sulfamethoxazole induced liver injury

Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors

Modulation of pharmacodynamic (PD) biomarkers in dermal biopsies from patients treated on a phase I study of bevacizumab (Bev) in combination with everolimus (Ev) and erlotinib (Erl) for advanced solid tumors

A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors

Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data: Supplement Issue: Array Platform Modeling and Analysis (A)

An Experiment for Background Subtraction in a Dynamic Scene

Suchergebnisse filtern